Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Moyle

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
Drugs|May 1, 1996
Current knowledge and future prospects for the use of HIV protease inhibitorsG Moyle, B Gazzard
Genitourinary Medicine|August 1, 1996
The role of HIV-proteinase inhibitorsB Gazzard, G Moyle
Lancet (London, England)|August 5, 1998
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing CommitteeB Gazzard, G Moyle
Expert Opinion on Investigational Drugs|February 1, 1997
To sequence or not to sequence?B Gazzard, G Moyle
AIDS (London, England)|March 1, 1997
The development of resistance of HIV-1 to zalcitabineC Craig, G Moyle
The AIDS Reader|September 1, 2000
Switching from a PI-based to a PI-sparing regimen for management of metabolic or clinical fat redistributionG Moyle, C Baldwin
HIV Medicine|April 28, 2007
Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trialsA Hill, G Moyle
Sexually Transmitted Infections|August 17, 1999
Commentary: resistance testing--a clinical perspectiveB G Gazzard, G Moyle
The American Journal of Medicine|March 1, 1995
Foscarnet or ganciclovir for treatment of AIDS and CMV retinitisG Moyle, B G Gazzard
Nature|November 11, 2005
Single origin of a pan-Pacific bird group and upstream colonization of AustralasiaChristopher E Filardi, Robert G Moyle
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Drugs|May 1, 1996
Current knowledge and future prospects for the use of HIV protease inhibitorsG Moyle, B Gazzard
Genitourinary Medicine|August 1, 1996
The role of HIV-proteinase inhibitorsB Gazzard, G Moyle
Lancet (London, England)|August 5, 1998
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing CommitteeB Gazzard, G Moyle
Expert Opinion on Investigational Drugs|February 1, 1997
To sequence or not to sequence?B Gazzard, G Moyle
AIDS (London, England)|March 1, 1997
The development of resistance of HIV-1 to zalcitabineC Craig, G Moyle
The AIDS Reader|September 1, 2000
Switching from a PI-based to a PI-sparing regimen for management of metabolic or clinical fat redistributionG Moyle, C Baldwin
HIV Medicine|April 28, 2007
Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trialsA Hill, G Moyle
Sexually Transmitted Infections|August 17, 1999
Commentary: resistance testing--a clinical perspectiveB G Gazzard, G Moyle
The American Journal of Medicine|March 1, 1995
Foscarnet or ganciclovir for treatment of AIDS and CMV retinitisG Moyle, B G Gazzard
Nature|November 11, 2005
Single origin of a pan-Pacific bird group and upstream colonization of AustralasiaChristopher E Filardi, Robert G Moyle
Pageof 15